ZELSAO Trademark

Trademark Overview


On Thursday, September 1, 2016, a trademark application was filed for ZELSAO with the United States Patent and Trademark Office. The USPTO has given the ZELSAO trademark a serial number of 87158254. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 10, 2024. This trademark is owned by Glaxo Group Limited. The ZELSAO trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neur...
zelsao

General Information


Serial Number87158254
Word MarkZELSAO
Filing DateThursday, September 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 10, 2024
Registration Number5320580
Registration DateTuesday, October 31, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "ZELSAO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Wednesday, December 14, 2016LETTER OF SUSPENSION E-MAILED
Monday, September 5, 2016NEW APPLICATION ENTERED
Wednesday, September 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2016ASSIGNED TO EXAMINER
Wednesday, December 14, 2016SUSPENSION LETTER WRITTEN
Wednesday, December 14, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, December 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 8, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 10, 2017ASSIGNED TO LIE
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Monday, October 31, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 10, 2024CANCELLED SEC. 8 (6-YR)